Diabetic foot syndrome and renal function in type 1 and 2 diabetes mellitus show close association

Nephrology Dialysis Transplantation

Volumn 24, Issue 6, 2009, Pages 1896-1901

  Wolf, Gunter ^a   Müller, Nicolle ^a   Busch, Martin ^a   Eidner, Gudrun ^a   Kloos, Christof ^a   Hunger Battefeld, Wilgard ^a   Müller, Ulrich A ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

Chronic kidney disease; Diabetes mellitus; Diabetic foot syndrome; Diabetic nephropathy

Indexed keywords

CREATININE; HEMOGLOBIN A1C;

ADULT; AGED; ALBUMINURIA; ARTICLE; CHRONIC KIDNEY DISEASE; CIGARETTE SMOKING; CLINICAL ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC FOOT; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOOD ANALYSIS; GLOMERULUS FILTRATION RATE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE; TERTIARY HEALTH CARE;

ADULT; AGED; AGED, 80 AND OVER; AMPUTATION; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC FOOT; DIABETIC NEPHROPATHIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 67651115800     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn724     Document Type: Article

References (27)

1. Sing N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA 2005; 293: 217-228
2. Ritz E, Orth SR. Nephropathy in patients with type 2 diabetes mellitus. NEnglJMed 1999; 341: 1127-1133
3. Schömig M, Ritz E, Standl E et al. The diabetic foot in the dialyzed patient. J Am Soc Nephrol 2000; 11: 1153-1159
4. Papanas N, Liakopoulos V, Maltezos E et al. The diabetic foot in end stage renal disease. Ren Fail 2007; 29: 519-528
5. O'Hare AM, Bachetti P, Segal M et al. Factors associated with future amputations among patients undergoing hemodialysis: results from the dialysis morbidity and mortality study waves 3 and 4. Am J Kidney Dis 2003; 41: 162-170
6. Margolis DJ, Hofstad O, Feldman HI. Association between renal failure and foot ulcer of lower-extremity amputation in patients with diabetes. Diabetes Care 2008; 31: 1331-1336
7. Wagner FW. The dysvascular foot: a system for diagnosis and treatment. Foot Ankle 1981; 2: 64-122
8. Armstrong DG, Lavery LA, Harkless LB. Validation of a diabetic wound classification system. Diabetes Care 1998; 21: 855-859
9. Levey AS, Bosch JP, Breyer-Lewis J et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new equation. Ann Intern Med 1999; 130: 461-470
10. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39(Suppl 2): S1-S266
11. Müller UA, Femerling M, Reinauer KM et al. Intensified treatment and education of type 1 diabetes as clinical routine. A nationwide quality-circle experience in Germany. ASD (the working groups on structured diabetes therapy of the German diabetes association). Diabetes Care 1999; 22(Suppl 2): B29-B34
12. Sämann A, Tajiyeva O, Müller N et al. Prevalence of the diabetic foot syndrome at the primary care level in Germany: a cross-sectional study. Diabetic Med 2008; 25: 557-563
13. O'Hare A, Glidden DV, Fox CS et al. High prevalence of peripheral arterial disease in persons with renal insufficiency. Results from the national health and nutrition examination survey 1999-2000. Circulation 2004; 109: 320-323
14. O'Hare A, Vittinghoff E, Hsia J et al. Renal insufficiency and the risk of lower extremity peripheral arterial disease: results from the heart and estrogen/progestin replacement study (HERS). J Am Soc Nephrol 2004; 15: 1046-1051
15. Stevens LA, Stoycheff N. Standardization of serum creatinine and estimated GFR in the kidney early evaluation program (KEEP). Am J Kidney Dis 2008; 51(Suppl 2): S77-S82
16. Myers GL, Miller WG, Coresh J et al. Recommendations for improving serum creatinine measurement: a report from the laboratory working group of the national kidney disease education program. Clin Chem 2006; 52: 5-18
17. Lavery LA, Armstrong DG, Vela SA et al. Practical criteria for screening patients at high risk for diabetic foot ulceration. Arch Intern Med 1998; 158: 157-162
18. Dinh TL, Veves A. A review of the mechanisms implicated in the pathogenesis of the diabetic foot. Low Extrem Wounds 2005; 4: 154-159
19. Bohlender JM, Franke S, Stein G et al. Advanced glycation end products and the kidney. Am J Physiol Renal Physiol 2005; 289: F645-F659
20. Rüster C, Bondeva T, Franke S et al. Advanced glycation end-products induce cell cycle arrest and hypertrophy in podocytes. Nephrol Dial Transplant 2008; 23: 2179-2191
21. Goova MT, Li J, Kislinger T et al. Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice. Am J Pathol 2001; 159: 513-525
22. Wendt TM, Tanji N, Guo J et al. RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy. Am J Pathol 2003; 162: 1123-1137
23. Pham TT, Sim JJ, Kujubu DA et al. Prevalence of nondiabetic renal disease in diabetic patients. Am J Nephrol 2007; 27: 322-328
24. Mühlhauser I, Overmann H, Bender R et al. Social status and the quality of care for adult people with type I (insulin-dependent) diabetes mellitus-a population-based study. Diabetologia 1998; 41: 1139-1150
25. Bryson CL, Ross HJ, Boyko EJ et al. Racial and ethnic variations in albuminuria in the US third national health and nutrition examination survey (NHANES III) population: associations with diabetes and level of CKD. Am J Kidney Dis 2006; 48: 720-726
26. McCabe CJ, Stevenson RC, Dolan AM. Evaluation of a diabetic foot screening and protection programme. Diabet Med 1998; 15: 80-84
27. Cavanagh PR, Lipsky BA, Bradbury AW et al. Treatment for diabetic foot ulcers. Lancet 2005; 366: 1725-1735